NCT06291285View on ClinicalTrials.gov

A Study to Test How Either a Capsule or a Tablet With NDec (Decitabine and Tetrahydrouridine) Works in the Body of Healthy People

PHASE1CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

June 10, 2024

Study Completion Date

June 10, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

Decitabine-THU

Orally administered immediate release tablets.

DRUG

Decitabine-THU

Orally administered delayed release capsules.

Trial Locations (1)

84124

ICON-Salt Lake City, Salt Lake City

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY